CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Shohini Nath
/ Categories: Trending, Markets

Overnight Digest: Stocks to look out for on July 12

The stocks that are likely to witness significant movement on the bourses on Thursday are Aurobindo Pharma, Power Grid Corporation of India, Idea Cellular Ltd, Reliance Industries Infrastructure and Sun Pharmaceutical Industries.

 

Aurobindo Pharma Ltd : The company has informed the bourses upon receiving the USFDA approval for Azithromycin Tablets, product to be launched this month. The market size of product is approximately 900 crore. The stock will be watched on Thursday

 

Power Grid Corporation Of India : The company has announced that the commercial Operation of POWERGRID Warora Transmission Limited (subsidiary of POWERGRID acquired under TBCB) will be put into commercial operation by 10th July, 2018. This will keep the stock in focus on Thursday.

 

Idea Cellular Ltd : The government has approved the Idea Cellular and Vodafone merger although some formalities remain to finally close the deal. This will keep the stock of Idea in focus on Thursday.

 

Reliance Industrial Infrastructure Ltd. : The company has submitted to the exchange the financial results for the period ending June 30, 2018. The company's bottom-line for Q1FY19 rose marginally by almost 4 per cent YoY to Rs.192 crore. The stock will be in focus on Thursday.

 

Sun Pharmaceutical Industries : DUSA Pharmaceuticals, Inc.,a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. files lawsuit against Biofrontera Inc. for patent infringement, trade secret misappropriation, and harmful interference. The stock will be watched on Thursday.

Previous Article Large-cap funds or aggressive hybrid funds, the choice is yours
Next Article Nice start for the markets expected riding on Asian optimism
Print
1687 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR